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The levels of c-fos and c-jun mRNA were measured by reverse
transcription PCR in the rabbit latissimus dorsi muscle following
three separate training regimes, i.e. passive stretch, 10 Hz elec-
trical stimulation or a combination of the two. Both c-fos and
c-jun mRNA expression peaked at around 1 h after imposing
stretch and at around 4.5-6 h after the initiation of electrical
stimulation. The combined stretch/electrical stimulation regime
induced biphasic expression of both c-fos and c-jun mRNA, with
peaks coinciding temporally with those for the individual regimes.
Immunostaining with anti-Fos and anti-Jun antibodies revealed
the accumulation of these proteins in both myofibre and in-
INTRODUCTION
Cellular oncogene expression is down-regulated in post-mitotic
striated muscle as muscle-specific genes are induced during muscle
differentiation [1]. Expression of c-myc, c-fos, c-jun and other
early response genes can be re-induced, in both cells in culture
and in intact tissues in vivo, in response to a range of diverse
stimuli [2,3]. In intact striated muscle, a variety of mechanical
stimuli have been shown to lead to a rapid (within a few hours)
and transient increase in the expression of a number of cellular
oncogenes. These include pressure overloading of the heart [4],
increasing coronary perfusion pressure [5], tenotomy of a func-
tional synergistic muscle or administration of ,8-agonists [6].
Since all of the above cause hypertrophy of the muscle it is
possible that changes in cellular oncogene expression are early
events in the signal cascade which leads to muscle hypertrophy.
The c-Fos and c-Jun proteins are components of the activator
protein-I (AP-1) transcription factor complex [7,8]. Other
members of the Fos and Jun gene families (e.g. Fos-B, Fra-1,
Jun-B, Jun-D) also form complexes which bind to AP-1 binding
sites. The mammalian AP-1 transcription factor comprises Fos-
Jun heterodimers or Jun-Jun homo- or hetero-dimers, forming a
variety of transcriptional regulators ([9] and refs. therein). The
cellular role of these proteins in many cells is in transcriptional
regulation as an adaptive response to external stimuli transduced
via second messengers [10]. However, such a role has not been
proven to occur in striated muscle tissue. In order to investigate
further the roles offos and jun cellular oncogenes in muscle cell
signalling we have studied their expression under conditions
known to induce either hypertrophy or alterations in gene
expression.
We have previously demonstrated that simultaneous stretching
and electrical stimulation (10 Hz) of skeletal muscle leads to both
transformation from glycolytic fast-twitch to oxidative slow-
terstitial cell nuclei following passive stretch. In contrast, fol-
lowing electrical stimulation the localization of immunoreactive
c-Fos and c-Jun proteins was predominantly in interstitial cell
nuclei. c-Fos and c-Jun immunoreactivity was also clearly co-
localized in a proportion of myonuclei from stretched muscle.
These findings suggest that the rapid induction of c-fos and c-jun
is an early event in response to mechanical stretch and might
trigger [via activator protein-I (AP-1) transcriptional factors]
events leading to muscle fibre hypertrophy. However, the in-
volvement of AP-1 in inducing the phenotypic changes in muscle
fibres as a result of electrical stimulation appears less clear.
twitch fibres and an increased rate of protein synthesis, leading
to muscle hypertrophy [11,12]. Either electrical stimulation
[13,14] or stretch alone [1 1,15] is capable of reprogramming gene
expression to bring about changes in muscle fibre types. Electrical
stimulation alone, however, causes substantial muscle atrophy
(up to 45 % after 3 weeks) [16,17]. Combining stretch with
electrical stimulation speeds up the muscle transformation pro-
cess significantly and produces muscle growth rather than atrophy
[1 1,12]. The anabolic effects of the combined mechanical regime
can be attributed to the stretch component [18].
In the present study we have employed reverse transcription
(RT)-PCR to investigate the temporal expression of c-fos and
c-jun mRNA in rabbit latissimus dorsi (LD), a predominantly
fast-twitch muscle [19], in response to three mechanical training
regimes (i.e. stretch alone, electrical stimulation alone or a
combination of both) to determine which induces the earliest
detectable changes. In addition, the cellular site of the increased
expression has been investigated using immunolabelling tech-
niques to determine the type and distribution of cells expressing
c-Fos and c-Jun as a result of either stretch alone or electrical
stimulation.
MATERIALS AND METHODS
Chemicals and DNA standards
The c-fos plasmid, comprising a 2.2 kbp rat cDNA insert cloned
into the HindIII-BamHI site ofpCMV, was donated by Matthew
Hope (University of Leeds). A 1.0 kbp v-jun sequence cloned into
the BamHI-EcoRI site ofpSPT19 was used as the c-jun standard.
Slow myosin primers were supplied by Kay Gillott (University of
Leeds). Taq DNA polymerase was purchased from Boehringer
Mannheim UK and AMV reverse transcriptase from Promega.
Sheep polyclonal antibodies against c-Fos and c-Jun were
purchased from Cambridge Research Biochemicals (OA1 1-824
Abbreviations used: RT, reverse transcription; AP-1, activator protein-1; LD, latissimus dorsi; DAB, 3,3'-diaminobenzidine.
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and OAl 1-837 respectively). Chemicals were either AnalaR or
molecular biology grade.
Operative procedures and experimental regimes
Dwarf Dutch rabbits, weighing 1-1.2 kg, were used throughout.
Rabbits were maintained under Halothane anaesthesia and full
aseptic procedures were employed for all operations. The rabbit
LD muscles were subjected to acute (0.25-24 h) stretch, electrical
stimulation or a combination of the two training regimes.
Passive stretch was imposed on the LD by the insertion of a
silastic tissue expander between the LD and the ribs through an
incision close to the spine and approximately half way along the
muscle's length. The insertion was closed around the tubing of
the expander and the filler port placed subcutaneously on the
animal's flank. Each tissue expander was filled with 40 ml of
sterile saline injected via the filler ports. This form of static
stretch extends the muscle approximately 15 % beyond its resting
length.
Electrical stimulation of the LD was achieved by the im-
plantation of stainless-steel electrodes below the LD across the
thoracodorsal nerve. Electrodes were attached to an external
stimulator which was carried on the rabbit's back in a jacket. The
stimulators delivered impulses of 3-5 V at a frequency of
10 +0.5 Hz with a pulse width of 1 ms.
Both procedures were carried out on animals undergoing
stretch and stimulation of the LD. Animals were allowed to
recover from the surgery for 24 h before the treatment protocols
commenced.
After the appropriate time period (i.e. between 0 and 24 h),
animals were humanely killed with an overdose of Sagatal
(pentobarbitone) administered via an ear vein. The skin on the
back was immediately opened and where muscles were taken for
RNA analysis the rabbit was plunged into ice-cold saline to chill
the LD. Both experimental and contralateral (i.e. internal control)
LD muscles were quickly dissected out and portions of muscle
from the central region were immediately frozen in liquid nitrogen
and stored at -80 'C. For immunocytochemical analysis LD
muscles were dissected dry. Small pieces from the centre of the
muscle were mounted between blocks of liver, embedded in
Tissue-Tek and dusted with fine talc before being flash frozen in
liquid nitrogen.
Additional control muscles were obtained from non-operated
and sham-operated animals. Sham stretch conditions were
obtained by fitting an uninflated expander under the LD and
sham electrical stimulation was achieved by implanting electrodes
and fitting a stimulator which was never switched on.
RNA extraction and analysis by PCR
Samples (approx. 100 mg) of contralateral and experimental
muscles were homogenized in 4 M guanidine isothiocyanate/
25 mM sodium citrate (pH 7)/0.5 % sarkosyl/0. 1 M 2-mercapto-
ethanol (1 ml/100 mg muscle) using a Polytron PT 10-35. Total
RNA was extracted from the muscle samples according to the
method of Chomczynski and Saachi [20]. A 2 ,ug aliquot of total
RNA (measured spectrophotometrically at 260 nm) from each
sample was subsequently reverse transcribed to yield cDNA as
follows: RNA was incubated at 65 'C for 10 min with 0.2 jug of
oligo (dT)l, primer and then snap-cooled on ice before incubation
at 42 'C for 1 h with AMV reverse transcriptase, RNasin
(ribonuclease inhibitor) and dNTPs. PCR was carried out on a
Techne PH-C thermal cycler. c-fos primers were designed (from
a consensus sequence of rat, mouse and human c-fos) to yield a
261 bp product spanning intron 2 so that genomic contamination
could be detected. The sequences of the forward and reverse c-fos
primers were 5'-ACCAGCCCAGACCTGCAGTGG-3' and 5'-
CCGGCACTTGGCTGCAGCCAT-3' respectively; these corre-
sponded to 63-84 bp downstream of intron 1 (forward primer)
and 57-36 bp upstream of intron 3 (reverse primer) on the c-fos
gene [21]. c-jun primers yielded a 267 bp product corresponding
to nucleotide numbers 1696-1963 on the c-jun gene [22]. The
c-jun primer sequences were: 5'-CCCCTGTCCCCCATCGAC-
ATG-3' (forward) and 5'-TTGCAACTGCTGCGTTAGCAT-3'
(reverse). PCR conditions were as follows: 28 (c-fos) or 24 (c-jun)
cycles at 95 °C for 1 min, 55 °C for 1 min, 72 °C for 1 min,
preceded by a denaturation step of 95 °C for 5 min and followed
by an elongation step of 72 °C for 10 min. DNA standards were
amplified alongside the cDNA samples: serial dilutions of rat
c-fos or v-jun plasmids were used to provide semi-quantitative
analysis of the samples. All cDNA samples and standards were
amplified in duplicate. PCR using rabbit slow myosin heavy
chain primers was carried out under previously determined
conditions (see [19]).
Competitive PCR was carried out using 'mimic' c-fos and c-
jun competitors [23]. These were created using composite primers
which had sequences complementary to a stretch of pBR322 and
also to c-fos or c-jun. PCR with the composite primers yielded a
product which had the c-fos or c-jun sequences spanning part of
the pBR322 sequence and was of a length designed to be
distinguishable from the target cDNA products on an agarose
gel, i.e. 218 and 206 bp for c-fos and c-jun mimics respectively,
compared with 261 and 267 bp for the authentic fos and jun.
c-fos and c-jun PCR products were sequenced using Promega
'fmol' sequencing kit according to the manufacturer's instruc-
tions.
PCR products were run on a 2% agarose/ethidium bromide
gel and the negative of a photograph of the gel was scanned using
an LKB laser densitometer. Reaction parameters were pre-
determined to ensure that amplification was within the expo-
nential phase and that the absorbance values measured by the
densitometer were within the linear range of the film.
The polyclonal antibodies used in this study were raised against
short synthetic peptide sequences selected from conserved regions
of mouse and human c-Fos or c-Jun (thus enhancing antibody
specificity). Localization of c-Fos and c-Jun immunoreactivity
was carried out using the peroxidase-labelled biotin/avidin
system (Vectastain Elite ABC kit, Vector Laboratories Ltd.).
Muscle was sectioned to 7 ,gm at -25 °C (serial sections cut to
5 ,um), thaw-mounted onto gelatine-dichromate coated slides
and air dried at room temperature for 1 h. Slides were subse-
quently stored at -80 'C. All incubations were carried out at
room temperature unless indicated otherwise. Sections were fixed
in ice-cold acetone for 30 min and endogenous peroxidase activity
removed by incubation in methanolic H202 (1 %) for a further
30 min. After rinsing in PBS (pH 7.4) the sections were non-
specifically blocked with normal horse serum (10 %) for 30 min.
The sections were then incubated overnight at 4 'C in a humidified
atmosphere with polyclonal immunoglobulins (IgG) directed
against c-Fos or c-Jun at respective dilutions of 1: 250 and
1:2000 in 10% horse serum in PBS. Following three washing
steps in PBS for 10 min each, the sections were incubated for 1 h
with biotinylated rabbit anti-(goat IgG) (Dako Ltd., U.K.)
diluted 1:400 in 10% horse serum in PBS. After rinsing, the
secondary antibody was revealed using the Vectastain ABC-
HRP kit. Peroxidase activity was visualized with 3,3'-diamino-
benzidine (DAB) (0.04 %) and H202 (0.01 %) and enhanced with
nickel chloride (0.05 %). Sections were then lightly stained with
c-fos and c-jun expression in rabbit skeletal muscle 467
eosin, dehydrated in ethanol, cleared into xylene and mounted
before being photographed.
Immunocytochemical controls to the experimental sections
were incubated as above, either replacing the anti-Fos or anti-
Jun antibodies with non-immune sheep serum, or omitting the
primary antibodies altogether. In addition, antibody specificity
was ascertained by pre-absorption of both polyclonals with their
respective peptide antigens (Cambridge Research Biochemicals)
and by immunoblot analysis.
Expression of results
c-fos and c-jun mRNA levels for experimental and contralateral
muscles are expressed as fold increases over external control
muscle values. Absorbance values (from experimental, contra-
lateral and external control samples) were converted into pico-
grams ofDNA using the standard curves and fold increases were
calculated from these numbers.
RESULTS
PCR
PCR amplification of the muscle cDNA samples with the c-fos or
c-jun primers gave single products when run on an agarose/
ethidium bromide gel, demonstrating that no genomic con-
tamination was present in the total RNA preparations (Figure
la). The sizes of the products (261 and 267 bp) were judged to be
correct when compared with a DNA bp ladder, and the PCR
products were shown to be those of c-fos or c-jun by sequencing
around 180 bp of each. Figures 1(b) and 1(c) shows a typical
standard curve obtained following PCR of the c-fos cDNA serial
dilution with c-fos primers.
The relative efficiency (between samples) of the RT step was
checked on selected batches ofcDNA by carrying out PCR using
primers to slow myosin heavy chain, since the expression of
myosin does not change in response to the experimental protocols
within the short time periods studied here (K. L. Gillott, V. M.
Cox and D. F. Goldspink, unpublished work). Fold increases
(over control values) of slow myosin mRNA in four randomly
selected batches of experimental samples ranged form 0.7 to 1.4,
demonstrating that myosin expression was uniform between
cDNA samples from a given batch. It was therefore concluded
that the RT step was consistent and reproducible between samples
and that routine myosin analysis for every cDNA sample was
unnecessary.
Results of the time-course of the expression of c-fos and c-jun
mRNA in response to either stretch, electrical stimulation or a
combination of stretch and stimulation are shown in Figures 2,
3 and 4. Sham-operated muscle samples showed baseline c-fos
and c-jun expression and in all cases values were not significantly
different from control (unoperated) values. Both c-fos and c-jun
showed peak expression at 1 h in LD muscles subjected to stretch
alone (Figures 2a and 2b). Whereas c-fos expression gave a
discrete peak at 1 h, c-jun expression was apparently more
complex and a secondary rise in expression was also seen at
around 4.5 h of stretch. Small, insignificant changes (relative to
external controls) were consistently found at all time-points in
the internal control (contralateral) LD muscles. The electrical
stimulation regime caused a later response, when compared with
stretch, in that the expression of both genes was highest after
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Figure 1 c-fos and c-jun PCR products and a PCR standard curve
(a) c-fos (left) and c-jun (right) PCR products. PCR products from experimental muscle samples were run on a 2% agarose gel stained with ethidium bromide. Discrete bands at 261 bp (c-fos;
lanes 2, 3 and 4) and 267 bp (c-jun; lanes 5, 6 and 7) are visible. A 123 bp DNA ladder was run in lanes 1 and 8. (b) PCR products of c-fos standard cDNAs run on an ethidium bromide-
stained agarose gel. (c) Plot of the absorbance of PCR product against the log of pg of c-fos cDNA standard.
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Figure 2 Time-course of c-los (a) and c-jun (b) mRNA expression in the Figure 3 Time-course of c-los (a) and c-jun (b) mRNA expression In the
LD subjected to passive stretch LD subjected to 10 Hz electrical sftmulafton
Data are presented for the experimental (@) and contralateral (O) muscles of three batches
of animals. Means + S.E.M. were calculated using Student's t test where P values refer to
significant differences from sham-operated values: *P < 0.1, **P < 0.05, ***P < 0.01.
approx. 4.5-6 h of initiating stimulation (Figures 3a and 3b). For
both genes, the peaks were broader than those produced by
stretch alone, although c-jun gave a broader message peak than
c-fos. For both the stretch and electrical stimulation regimes, the
magnitude of the fold increases for the two genes was similar and
was of the order of 15- to 20-fold when compared with values for
either external control or sham muscles. Values derived from the
contralateral control muscles were only slightly elevated above
external control values.
When stretch and electrical stimulation were combined, c-fos
and c-jun mRNA were both expressed in a biphasic manner, with
the peaks coinciding temporally with the peaks obtained for the
individual regimes (Figures 4a and 4b). For c-fos, the secondary
peak was smaller (around 7-fold that of the control) compared
with the first peak (16-fold) at 1 h. The reverse was true, however,
of the expression of c-jun. Here, the 4.5-6 h peak was around
twice the magnitude of the earlier peak at 1 h. Once again,
contralateral muscles gave values for c-fos and c-jun expression
which were not statistically different from baseline values.
Competitive PCR, using specifically designed c-fos and c-jun
competitors, was undertaken to obtain more accurate quan-
titative measurements on selected samples and to confirm the
Data presented as in Figure 2.
results given above (Table 1). One experimental sample (around
peak expression) and one contralateral sample from each training
regime was analysed for c-fos and c-jun mRNA. Results are
again expressed as fold increases to enable direct comparisons
with the external standard (semi-quantitative) method. Both
PCR methods yielded fold increases which were very similar (see
Table 1), thus validating our more extensive use of non-
competitive RT-PCR using external standards.
Immunocytochemistry
The early, transient induction of c-fos and c-jun mRNA is
accompanied by an accumulation of their respective protein
products in the mechanically stimulated muscles. c-Fos and
c-Jun immunoreactivity was barely detectable in sections of
external control muscles (Figures 5a and Sb), even following
prolonged incubation (up to 1 h) with the DAB substrate.
Sections from muscles which had undergone 10 Hz electrical
stimulation for 6 h demonstrated c-Fos immunoreactivity almost
exclusively in non-myofibre nuclei (Figure Sc). The distribution
of c-Jun immunoreactivity in the same muscles largely corre-
sponded to that seen with c-Fos, although a small proportion of
myofibre nuclei stained positive for the former (Figure 5d). In
contrast, sections from muscles which had been passively
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Figure 4 Time-course of c-fos (a) and c-jun (b) mRNA expression In the
LD subjected to passive stretch plus 10 Hz eiectrical stimulation
Data presented as in Figure 2.
Table 1 Fold increases in c-fos or c-jun expression (compared with
contralateral muscle): comparison of competitive and non-competitive PCR
methods
For each regime, an experimental muscle sample and a sample from its contralateral muscle
were analysed for c-fos and c-jun mRNA by competitive PCR (using a c-fos or c-jun mimic)
and by non-competitive PCR (using external standards). Results are expressed as fold increases
in the experimental samples compared with the contralaterals.
Fold increase
Samples Competitive Non-competitive
Regime [time (h)] PCR PCR
c-fos
Stretch
Electrical
stimulation
Combined
c-jun
Stretch
Electrical
stimulation
Combined
6.3
9.4
5.5
12.3
5.3
2.4
3.2
4.3
8
0.5 4.0
2.2
3.03
3.3
Figure 5 Cellular localization of Fos and Jun immunoreactivity in sections
from control, electrically stimulated and stretched LD
All sections were cut to 7 ,um and immunostained for either c-Fos (a, c, e and g) or c-Jun (b,
d, f and h). These are representative sections of control (a and b), 4.5 h electrically stimulated
(c and d) and 6 h stretched (e and f) muscles. Scale bar = 80 1am. Photographs (g) and (h)
are higher magnifications of (e) and (f) respectively, allowing localization of immuno-positive
nuclei relative to the plasma membrane of the fibres. Solid arrowheads show immunostaining
within myofibres and open arrowheads show staining of interstitial cell nuclei. Scale bar =
60 ,rm.
Figure 6 Co-localization of Fos and Jun immunoreactivity in serial sections
from stretched LD
Serial sections were cut to 5 ,um and alternately immunostained for either c-Fos (a) or c-Jun
(b). Arrowheads show analogous, positively stained myonuclei in each section. Scale bar =
60 ,um.
stretched for 4.5 h showed strong c-Fos and c-Jun immuno-
reactivity within nuclei of both myofibres and interstitial cells
(Figures 5e and 5f). The localization of these cellular oncoproteins
within the myofibres is more clearly seen at higher magnification
(Figures 5g and 5h). Serial sections (4-5 ,tm) were also taken
from stretched muscles to establish whether the c-Fos and c-Jun
proteins could be co-localized within the same nuclei. Results
shown in Figures 6a and 6b verify that Fos/Jun co-localization
was detectable in a proportion of the myonuclei.
**
1
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Figure 7 Staining of slow, oxidative fibres In control LD by the Jun
polyclonal antibody
Serial sections were cut to 7 1um and alternately stained for either c-Jun (a) or myosin ATPase
(b). Stars in (a) highlight fibres stained with the Jun antibody. These clearly correspond to the
slow, oxidative fibres which are light-staining after a pre-incubation at pH 10.4 (b) (for methods
see [19]). Scale bar = 50 ,um.
Very similar patterns of c-Fos and c-Jun expression were seen
in muscles which had been electrically stimulated for either
shorter (i.e. 4.5 h) or longer (i.e. 8 h) periods than those in
Figures 5c and Sd. Similar results to those shown in Figures 5(e)
and 5(f) were obtained with muscles stretched for 3 or 6 h (results
not shown).
Although we are unable to explain this phenomenon at present,
the c-Jun antibody appeared to interact with a small proportion
of the fibres in both control and experimental muscles (Figures
5b, Sd, Sf and 5h). Using a well established myosin ATPase
histochemical technique (for methods see [19]) we have shown
that the c-Jun polyclonal antibody also stained slow, oxidative
fibres (Figures 7a and b). This staining, together with all the
staining patterns for c-Fos and c-Jun in the experimental muscles,
was abolished when the sections were incubated with non-
immune sheep serum or with pre-absorbed primary antibodies
(results not shown). The specificities of the primary antibodies
were confirmed by detection of single bands on immunoblots of
experimental LD muscle extracts (results not shown).
DISCUSSION
In this study we have demonstrated both the rapid induction of
mRNA and nuclear accumulation of c-Fos and c-Jun gene
products in skeletal muscle subjected to mechanical training in
vivo, using either stretch alone, electrical stimulation at 10 Hz or
a combination of both.
Although similarly co-expressed, the time-courses of the in-
duction of c-jun mRNA were generally more complex than those
of c-fos. Whereas c-fos was induced only transiently (see Figures
2a, 3a and 4a), c-jun mRNA was detected over longer time
periods and apparently re-induced to provide a secondary peak
in response to stretch (see Figures 2b, 3b and 4b). One possible
explanation for these differences is that c-jun transcription is
positively regulated by its own product [24], whereas c-Fos
down-regulates its own expression [25]. This might also account
for the increased magnitude of the second c-jun peak following
stretch plus electrical stimulation (Figure 3c) and the decreased
magnitude of the corresponding c-fos peak (Figure 2c). The
picture is further complicated, however, by the fact that another
member of the Jun family, Jun-B, negatively regulates c-jun
expression [24] and other members of the Fos family undoubtedly
have a role in regulating c-fos expression.
Electrical stimulation of the LD led to peak expression of c-fos
and c-jun at around 4.5-6 h, i.e. at least 3 h after peak expression
in response to the stretch stimulus. In a preliminary study, we
have also shown that the patterns of expression reported here are
similar to those found in a hind limb muscle, the extensor
digitorum longus, following electrical stimulation or stretch by
limb immobilization [26].
Upon combining stretch with electrical stimulation, biphasic
expression of both c-fos and c-jun was induced; the timing of the
two peaks coinciding with the responses to each individual
stimulus and suggesting that stretch and electrical stimulation
may trigger cellular oncogene expression via separate signalling
pathways.
The use of immunocytochemistry enabled us to answer three
important questions: (i) are the increases in c-fos and c-jun
mRNA reflected in an accumulation of their respective protein
products, (ii) in which cell type are the c-Fos and c-Jun proteins
being expressed, and (iii) are these two proto-oncogenes co-
expressed within the same nuclei. The results clearly show that
following both electrical stimulation and stretch, the induction of
c-fos and c-jun mRNA does give rise to increased levels of the
corresponding proteins.
Although electrical stimulation ofthe LD resulted in prominent
c-Fos and c-Jun immunoreactivity, the vast majority of these
nuclei were associated with interstitial cells and not those of the
myofibres. In keeping with observations in vitro [27], these
changes in the interstitial cells are probably associated with cell
proliferation. This would be consistent with the known rapid
increase in capillary density following continuous electrical
stimulation [13]. The activation of fibroblasts to divide and
secrete more collagen may ultimately increase the passive re-
sistance of these muscles, thereby affecting their mechanical
performance. Another possibility involves the infiltration of
macrophages, if the stimulation protocol causes any muscle
damage or inflammation.
In contrast to these changes, passively stretching the LD
muscle led to a rapid and transient peak expression of c-fos and
c-jun message after 1 h (Figure 2). Fos and Jun proteins were
clearly localized within nuclei of the myofibres, as well as
interstitial cells (Figure 5). Hence, stretch activates the myonuclei
and/or the satellite cells and induces muscle fibre hypertrophy
[11,28].
A few studies have attempted to investigate the possible role of
proto-oncogenes in the induction of cardiac hypertrophy. For
example, Schunkert et al. [29] reported similar temporal changes
in cardiac muscle c-fos and c-jun message levels to those reported
here when the wall stress of the heart was increased during
systole. However, in pressure-overloaded hearts, c-fos expression
was found to be maximal somewhat later after 3-8 h [4,30]. An
accumulation of Fos protein has also been demonstrated in the
myocyte nuclei, with minimal staining of fibroblasts and vascular
smooth muscle, of isolated rat hearts subjected to acute pressure
overload [29]. c-Myc has also been localized in cardiomyocytes
following haemodynamic overload in vivo [31]. However, the
acute pressure changes imposed on the ventricles in such studies
could conceivably cause myocyte damage. If so, this could
complicate the interpretation of these findings as c-myc mRNA
levels are known to rise transiently in association with the
damage inflicted on the fibres of the anterior LD muscle of the
chicken [32].
Two important findings of this study were the co-expression of
c-fos and c-jun mRNA (Figure 2) and the co-localization of Fos
and Jun proteins within the myonuclei (Figure 6) of the stretched
LD. Even larger numbers of Fos/Jun positive nuclei might have
been detected had it been possible to cut even thinner serial
sections (< 3 ,um). Although still speculative at this stage, our
hypothesis is that these two proto-oncogenes, probably via the
AP-1 transcription factor, activate other growth-related genes,
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which in turn initiate muscle fibre hypertrophy through an
autocrine/paracrine action. We know, for example, that insulin-
like growth factor-I message levels are markedly elevated in
association with the rapid hypertrophic response to stretch
[18,28]. When examined histologically, the same stretched
muscles showed a small increase in the connective tissue content
around some muscle fibres, but the fibres themselves were
undamaged. Therefore, the localization of Fos and Jun proteins
within the nuclei of these stretched post-mitotic fibres suggests
that these oncoproteins may play an important role in the early
induction of muscle hypertrophy. This contrasts with the almost
total absence of nuclear staining for these oncoproteins in the
electrically stimulated muscles (Figures 5c and 5d), whose fibres
undergo dramatic atrophy and not hypertrophy [16]. Also, in
sharp contrast to electrical stimulation, passive stretch does not
change the metabolic and contractile properties of the muscle
fibres (R. James, J. D. Altringham, I. S. Young, V. M. Cox and
D. F. Goldspink unpublished work). Taken together, this
suggests that while these genes may be important in inducing
fibre hypertrophy, they are unlikely to be directly involved in
initiating the well-established changes in the phenotypic pro-
perties ofmuscles when subjected to chronic electrical stimulation
[13].
The present results indicate that under conditions known to
induce muscle hypertrophy in vivo (i.e. stretch), c-fos and c-jun
are activated in the nuclei of post-mitotic fibres. Although the
same genes are activated by electrical stimulation, this mainly
occurs in cells of the interstitial tissue and the fibres themselves
undergo atrophy [16]. Thus, the expression of these two proto-
oncogenes differ in both their timing and cellular localization
following two different types of mechanical stimulation.
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